Woman and Man
- | Country :
- Korea, Republic of
- Israel
- United Kingdom
- The 16 others...
- | organs : -
- | Specialty : -
Extract
BUILD 3 is a prospective, multicenter, randomized, double-blind, parallel group, placebo-controlled, event-driven, group sequential, phase III superiority study. The primary objective is to demonstrate that bosentan delays disease worsening or death in patients with Idiopathic Pulmonary Fibrosis.
Inclusion criteria
- Idiopathic pulmonary fibrosis